Personal information

Activities

Works (19)

Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell–Mediated Cytotoxicity

The Journal of Immunology
2024-04-15 | Journal article
Contributors: Zachary L Z Hay; Dale D Kim; Jennifer M Cimons; Jennifer R Knapp; M Eric Kohler; Mary Quansah; Tiffany M Zúñiga; Faye A Camp; Mayumi Fujita; Xiao-Jing Wang et al.
Source: check_circle
Crossref

Data from Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

2023-04-03 | Preprint
Contributors: Kelsey W. Nassar; Jennifer D. Hintzsche; Stacey M. Bagby; Veronica Espinoza; Christophe Langouët-Astrié; Carol M. Amato; Tugs-Saikhan Chimed; Mayumi Fujita; William Robinson; Aik Choon Tan et al.
Source: check_circle
Crossref

Data from Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

2023-04-03 | Preprint
Contributors: Kelsey W. Nassar; Jennifer D. Hintzsche; Stacey M. Bagby; Veronica Espinoza; Christophe Langouët-Astrié; Carol M. Amato; Tugs-Saikhan Chimed; Mayumi Fujita; William Robinson; Aik Choon Tan et al.
Source: check_circle
Crossref

Supplementary File S1 from Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

2023-04-03 | Preprint
Contributors: Kelsey W. Nassar; Jennifer D. Hintzsche; Stacey M. Bagby; Veronica Espinoza; Christophe Langouët-Astrié; Carol M. Amato; Tugs-Saikhan Chimed; Mayumi Fujita; William Robinson; Aik Choon Tan et al.
Source: check_circle
Crossref

Supplementary File S1 from Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

2023-04-03 | Preprint
Contributors: Kelsey W. Nassar; Jennifer D. Hintzsche; Stacey M. Bagby; Veronica Espinoza; Christophe Langouët-Astrié; Carol M. Amato; Tugs-Saikhan Chimed; Mayumi Fujita; William Robinson; Aik Choon Tan et al.
Source: check_circle
Crossref

Supplementary Tables and Figures from Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

2023-04-03 | Preprint
Contributors: Kelsey W. Nassar; Jennifer D. Hintzsche; Stacey M. Bagby; Veronica Espinoza; Christophe Langouët-Astrié; Carol M. Amato; Tugs-Saikhan Chimed; Mayumi Fujita; William Robinson; Aik Choon Tan et al.
Source: check_circle
Crossref

Supplementary Tables and Figures from Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

2023-04-03 | Preprint
Contributors: Kelsey W. Nassar; Jennifer D. Hintzsche; Stacey M. Bagby; Veronica Espinoza; Christophe Langouët-Astrié; Carol M. Amato; Tugs-Saikhan Chimed; Mayumi Fujita; William Robinson; Aik Choon Tan et al.
Source: check_circle
Crossref

Ethanol Metabolism and Melanoma

Cancers
2023-02-16 | Journal article
Contributors: Zili Zhai; Takeshi Yamauchi; Sarah Shangraw; Vincent Hou; Akiko Matsumoto; Mayumi Fujita
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Alcohol as a Non-UV Social-Environmental Risk Factor for Melanoma

Cancers
2022-10-13 | Journal article
Contributors: Takeshi Yamauchi; Sarah Shangraw; Zili Zhai; Dinoop Ravindran Menon; Nisha Batta; Robert P. Dellavalle; Mayumi Fujita
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells

Cells
2022-08-18 | Journal article
Contributors: Douglas Grant Osborne; Joanne Domenico; Mayumi Fujita
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Global Melanoma Correlations With Obesity, Smoking, and Alcohol Consumption

JMIR Dermatology
2021-12-13 | Journal article
Contributors: Nisha Batta; Sarah Shangraw; Andrew Nicklawsky; Takeshi Yamauchi; Zili Zhai; Dinoop Ravindran Menon; Dexiang Gao; Robert P Dellavalle; Mayumi Fujita
Source: check_circle
Crossref

EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses

Pharmaceuticals
2021-10-26 | Journal article
Contributors: Dinoop Ravindran Menon; Yang Li; Takeshi Yamauchi; Douglas Grant Osborne; Prasanna Kumar Vaddi; Michael F Wempe; Zili Zhai; Mayumi Fujita
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

Molecular Cancer Therapeutics
2021-10-01 | Journal article
Contributors: Kelsey W. Nassar; Jennifer D. Hintzsche; Stacey M. Bagby; Veronica Espinoza; Christophe Langouët-Astrié; Carol M. Amato; Tugs-Saikhan Chimed; Mayumi Fujita; William Robinson; Aik Choon Tan et al.
Source: check_circle
Crossref

Global Melanoma Correlations With Obesity, Smoking, and Alcohol Consumption (Preprint)

2021-06-23 | Preprint
Contributors: Nisha Batta; Sarah Shangraw; Andrew Nicklawsky; Takeshi Yamauchi; Zili Zhai; Dinoop Ravindran Menon; Dexiang Gao; Robert P Dellavalle; Mayumi Fujita
Source: check_circle
Crossref

Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects

European Journal of Immunology
2021-03 | Journal article
Contributors: Dennis M. de Graaf; Martin Jaeger; Inge C. L. van den Munckhof; Rob ter Horst; Kiki Schraa; Jelle Zwaag; Matthijs Kox; Mayumi Fujita; Takeshi Yamauchi; Laura Mercurio et al.
Source: check_circle
Crossref

NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma

Pharmaceuticals
2020-12-30 | Journal article
Contributors: Zili Zhai; Prasanna K. Vaddi; Jenny Mae Samson; Tomoya Takegami; Mayumi Fujita
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma

Cancers
2020-09-04 | Journal article
Contributors: Zili Zhai; Jenny Mae Samson; Takeshi Yamauchi; Prasanna K. Vaddi; Yuko Matsumoto; Charles A. Dinarello; Dinoop Ravindran Menon; Mayumi Fujita
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma

Cancers
2020-08 | Journal article | Author
Contributors: Nabanita Mukherjee; Carol Amato; Jenette Skees; Kaleb J. Todd; Karoline A. Lambert; William A. Robinson; Robert Van Gulick; Ryan M. Weight; Chiara R. Dart; Richard P. Tobin et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Melanoma to Vitiligo: The Melanocyte in Biology & Medicine–Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting

Journal of Investigative Dermatology
2020-02 | Journal article
Contributors: Sancy A. Leachman; Thomas J. Hornyak; Greg Barsh; Boris C. Bastian; Douglas E. Brash; James E. Cleaver; Cynthia D. Cooper; John A. D’Orazio; Mayumi Fujita; Sheri L. Holmen et al.
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for Nature communications (1)